India Glycols Ltd Q2 FY26 | ₹1,092 Cr Sales, ₹65 Cr PAT, and ₹466 Cr Fundraising Drama – Ethanol Meets IMFL with a Side of Tax Trouble!
1. At a Glance
India Glycols Ltd (IGL) — the desi scientist who turned molasses and corn into profit cocktails — just served another quarter that smells like ethanol and excitement. As of 21 November 2025, the stock trades at ₹1,127 with a market cap of ₹6,984 crore. The company’s latest quarterly sales touched ₹1,092 crore, up 13.6% YoY, while profit jumped 30.9% YoY to ₹65 crore.
With an OPM of 14.5%, ROE of 11.1%, and a debt pile of ₹2,055 crore (debt-to-equity 0.86), IGL looks like that friend who works hard, drinks responsibly, and still somehow ends up at the tax department’s party (because yes, there’s a ₹33 crore duty demand and ₹82 crore penalty sitting in its mailbox).
Over the past year, the stock has nearly doubled (+98.9%), and the recent ₹466.99 crore preferential issue is fueling expansion dreams across its ethanol, spirits, and specialty chemical empire. One question though — can a green chemical giant stay “clean” when it’s distilling both biofuel and vodka?
2. Introduction
Let’s be honest — India Glycols isn’t your average FMCG or chemical stock. It’s a company that brews industrial solvents and human solvents (read: liquor) under the same corporate umbrella. Founded in 1988, IGL has grown into a green chemistry giant blending sustainability with spirits, and ethanol with entertainment.
Its portfolio includes bio-based chemicals, glycols, glycol ethers, natural gums, industrial gases, nutraceuticals, and a wide range of alcoholic beverages. Imagine a lab that can supply fuel for your car and your Friday night — that’s IGL.
Over the years, the company has been on an expansion binge — setting up ethanol plants in Gorakhpur and Kashipur, commissioning biofuel projects, and launching “Soulmate Blu” whiskey and “Amazing” vodka (which, ironically, is what analysts said about its latest profit margins).
The real plot twist came when IGL started flexing in three worlds at once: chemicals, spirits, and nutraceuticals — while also planning a demerger into separate listed entities for Bio Pharma and Spirits undertakings. Why? Because when your chemistry is too complicated, you file for separation.
So as FY26 unfolds, IGL is sitting on growth engines — ethanol allocations from OMCs, nutraceutical exports, and that ₹467 crore fundraising. But let’s not forget the ₹82 crore customs penalty still looming — because even green chemistry sometimes ends in red notices.
3. Business Model – WTF Do They Even Do?
IGL’s business model is a three-way hybrid between a distillery, a chemical lab, and a health food startup.
Segment 1: Bio-based Specialties & Performance Chemicals (64%) This is the scientific side of IGL. They make glycol ethers, acetates, ethylene oxide derivatives, amines, and industrial gases. These are used in food, FMCG, personal care, automotive, and paints. Basically, every product that promises to “shine,” “clean,” or “smoothen” probably has a few molecules of IGL chemistry inside it.
Segment 2: Potable Spirits (28%) This is the fun side. IGL manufactures whiskey, vodka, and rum under brands like Soulmate Blu, Amazing, and Zumba. They dominate the flavored vodka category in tetra packs (yes, tetra packs), holding a 40%+ market share in their segment. Sales are concentrated in UP, Uttarakhand, and Delhi — with eyes on Haryana and Punjab (because what’s expansion without Punjab?).
Segment 3: Ennature Biopharma (7%) This is the Zen side. IGL’s Dehradun-based subsidiary produces plant-based APIs and nutraceuticals like curcumin, astaxanthin, and thiocolchicoside. It even got a clean chit from the USFDA in April 2025 — zero observations, which is rarer than a politician admitting a mistake.
If all that wasn’t enough, IGL is also into biofuel ethanol, supplying to oil majors like IOCL, BPCL, HPCL, RIL, and Nayara Energy — 16.55 crore liters worth ₹1,164 crore to be precise. Basically, they’re filling both fuel tanks and hip flasks.
